Search results
Immunis to use MRI-based AI muscle analysis for sarcopenia trial
Medical Device Network· 14 minutes agoImmunis has enlisted the services of Springbok Analytics in its Phase I/II clinical trial for a...
Viking’s new dual GLP-1R/GIPR agonist expected to start Phase III trials soon
Clinical Trials Arena· 14 minutes agoAmerican biopharmaceutical company Viking Therapeutics is actively developing several candidates...
Mouth Taping for Sleep: Is It Safe and Does It Actually Work?
Verywell Health· 51 minutes agoCognitive behavioral therapy, a form of phsychotherapy (or talk therapy), for insomnia is the...
Inside the efforts to rescue a rare disease gene therapy
Pharmaceutical Technology· 1 hour ago“It was such a traumatic experience for us,” shared Hailey. However, Hailey and Jeff had heard about...
Cue Biopharma downsizes to focus on autoimmune pipeline
Pharmaceutical Technology· 1 hour agoThe combination therapy demonstrated an overall survival rate of 46%, compared to 19% with the PD-1...
How Aaron Fox Skied 200 Days After Shattering His Femoral Neck
POWDER Magazine· 1 hour agoHow do you lure a Tahoe local away from home during a record-breaking snow season? More snow, of...
How Paris Olympics 2024 is prioritising mental health for athletes
Firstpost· 1 hour agoIn recent years, depression has been talked about more freely than it was ever before. Ahead of the...
Fly often? Check out rawdogging, the trendy minimal flight 'routine' that will get you...thinking
Hindustan Times· 2 hours agoFlights can be fun. But one too many don't take long to start feeling tedious. Fret not for the...
Cipla net profit jumps 17.4% to Rs 1,178 crore in Q1FY25
The Economic Times· 3 hours agoDrug maker Cipla reported a 17.4% year-on-year (YoY) jump in net profit to Rs 1,178 crore in Q1FY25,...
Could greater adoption of mobile nursing visits lead to faster study results?
Clinical Trials Arena· 3 hours agoAs sponsors seek to minimize trial delays and get new therapies to market faster, we explore whether...